ARCHIVES

NCI Names Brawly Director of Office of Special Populations

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985

Maryland Contract Leafs New FY Awards

July 25, 1975

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975